Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
bioSeedin Expanded Global Licensing and Partnership Opportunities at 2024 BIO International Convention 2024-06-26 21:00
Positive Xanamem® biomarker trial published in the Journal of Alzheimer's Disease demonstrating potential Xanamem efficacy in patients with elevated blood pTau 2024-06-26 20:56
Antengene Announces XPOVIO® (selinexor) National Health Insurance Service Approval for Reimbursement in South Korea 2024-06-26 16:44
Hyundai Bioscience succeeds in developing 'Multi-treatment for mosquito-borne viral infections' including Dengue Fever 2024-06-26 09:17
Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO & CDMO services 2024-06-25 20:00
CLL Community Urges Hospital Authority to List Next-Generation BTK Inhibitor on Drug Formulary to Bring Hope and Improve Quality of Life for CLL Patients 2024-06-25 17:00
Innovent Announces Mazdutide Demonstrates 80.2% Reduction in Liver Fat Content in Exploratory Analysis of Phase 3 Weight Management GLORY-1 Study at ADA 2024 2024-06-25 08:00
Science and Technology Daily: China's Fertile Grounds for Innovation 2024-06-24 21:41
Bota Bio's Biomanufacturing Technology is Commercialized at NHU with A Successful Strategic Partnership Established 2024-06-24 21:00
TiumBio Presents Promising Clinical Data from Phase 1 of its Hemophilia Treatment Candidate TU7710 at ISTH 2024 2024-06-24 20:00
iRegene Receives IND approval from U.S. FDA to Start Clinical Trial for Parkinson's Disease 2024-06-24 20:00
Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Molecular Profiling in the Middle East and Africa 2024-06-24 09:00
Ascentage Pharma Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering of American Depositary Shares 2024-06-24 08:15
Sciwind Biosciences to Highlight Positive Results for Injectable Ecnoglutide (Phase 3), Oral Ecnoglutide (Phase 1), and Novel Amylin Analogs at the American Diabetes Association (ADA) 84th Annual Conference 2024-06-22 07:00
Biocytogen Awarded U.S. Patent for RenLite® Common Light Chain Mouse Platform 2024-06-21 17:45
Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda 2024-06-21 09:19
Keymed Biosciences Announces Safety and Efficacy Results of CM313 for Primary Immune Thrombocytopenia Published in NEJM 2024-06-20 14:51
GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group 2024-06-20 08:44
CMT Research Foundation Invests in ReviR Therapeutics Research to Pioneer Small Molecule Therapeutics for CMT1A 2024-06-19 21:00
Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma 2024-06-19 19:30
1 26 27 28 29 30 451